http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-200824699-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79da59acb0b0ebeb74b07a9a8d5fd2c4 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 |
| filingDate | 2006-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3826f3b4dbbdce9fa9e7582db2db777a |
| publicationDate | 2008-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-200824699-A |
| titleOfInvention | Arsenic compounds for the treatment of the arsenic-sensitive blast-cell related diseases |
| abstract | The present invention is related to arsenic compounds for the arsenic-sensitive blast-cell related diseases, such as hypersensitivity diseases, immunologic diseases, fibroblastic diseases, inflammatory diseases and infectious diseases, more particularly, the present invention is related to the treatment for malaria, Trypanosoma, bronchial asthma and systemic lupus erythematosus. |
| priorityDate | 2005-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 144.